Phase Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Data at week 48 demonstrated that treatment with pegozafermin led to sustained statistically significant improvements across liver fat and non-invasive tests of liver injury/inflammation and.

United statesSan franciscoHank mansbachAnnie changSheryl seapyDrug administrationLifesci advisorsExchange commissionChief medical officerExtension phaseMain studyPhase dataTreatment effects were robustPatient sub groupsLipids resultsBreakthrough therapy